Yellow fever mortality in Brazil: an age-period-cohort study
DOI:
https://doi.org/10.11606/s15188787.2025059006721Palavras-chave:
Yellow Fever, Mortality, BrazilResumo
OBJECTIVE: To analyze yellow fever mortality trends in Brazil, focusing on sexes differences and using an age-period-cohort model. METHODS: This ecological study analyzed yellow fever mortality data in Brazil from 1980 to 2019 sourced from Datasus. Population estimates were retrieved from the Instituto Brasileiro de Geografia e Estatística (Brazilian Institute of Geography and Statistics). Mortality data, including age, year of death, and cause (ICD-9: 060; ICD-10: A95), were analyzed using an age period cohort model. A Poisson distribution was assumed for mortality counts, and analyses were conducted using Holford’s method and its adaptations on R. RESULTS: The results show that the incidence rate peaked at younger ages, such as 30 years (0.010/100,000 individuals, 95%CI: 0.008/100,000 to 0.013/100,000), followed by a gradual declining trend with increasing age, reaching 0.007/100,000 individuals (95%CI: 0.005/100,000 to 0.010/100,000) at 50 years onward. Regarding period, a substantial increase in the adjusted hazard ratio occurred over time, especially in 2015 (13.923 [95%CI: 11.095 to 17.471]), suggesting a significant elevation when compared with previous periods. Cohort analysis showed a trend of increasing risk until 1960 (RR = 1.000), followed by a marked reduction for more recent cohorts, such as 2010: RR = 0.056 (95%CI: 0.028 to 0.112). Vaccination analysis showed alternating periods of significant increases and decreases in vaccination rates. CONCLUSIONS: Younger individuals showed higher mortality rates, with a gradual decline with advancing age. Period effects highlighted a pronounced resurgence in recent years, particularly during the 2015 epidemic, underscoring the influence of temporal factors such as outbreaks and vaccination campaigns. Cohort analysis showed a progressive decline in mortality risk among more recent birth cohorts, likely reflecting the impact of expanded immunization programs and improved public health measures. The proposed yellow fever vaccination trends in Brazil may explain some of the observed patterns.
Referências
Grahn E, Picard J, Simon LV, Hashmi MF, Torp KD. Yellow fever. In: StatPearls. Treasure Island: StatPearls Publishing; 2023.
Nwaiwu AU, Musekiwa A, Tamuzi JL, Sambala EZ, Nyasulu PS. The incidence and mortality of yellow fever in Africa: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):1089. https://doi.org/10.1186/s12879-021-06728-x
Silva NIO, Sacchetto L, Rezende IM, Trindade GS, LaBeaud AD, Thoisy B, et al. Recent sylvatic yellow fever virus transmission in Brazil: the news from an old disease. Virol J. 2020;17(1):9. https://doi.org/10.1186/s12985-019-1277-7
Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics. 1983;39(2):311-24. https://doi.org/10.1002/sim.4780060406
Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: age-period-cohort models. Stat Med. 1987;6(4):469-481. https://doi.org/10.1002/sim.4780060406
Carstensen B. Age–period–cohort models for the Lexis diagram. Stat Med. 2007;26(15), 3018-3045. https://doi.org/10.1002/sim.2764
Cunha MS, Tubaki RM, Menezes RMT, Pereira M, Caleiro GS, Coelho E, et al. Possible non-sylvatic transmission of yellow fever between non-human primates in São Paulo City, Brazil, 2017-2018. Sci Rep. 2020;10(1):15751. https://doi.org/10.1038/s41598-020-72794-x
Hamer DH, Angelo K, Caumes E, van Genderen PJJ, Florescu AS, Popescu CP, et al. Fatal yellow fever in travelers to Brazil, 2018. MMWR Morb Mortal Wkly Rep. 2018;67(11):340-1. https://doi.org/10.15585/mmwr.mm6711e1
Figueiredo PO, Stoffella-Dutra AG, Costa GB, Oliveira JS, Amaral CD, Santos JD, et al. Re-emergence of yellow fever in Brazil during 2016-2019: challenges, lessons learned, and perspectives. Viruses. 2020;12(11):1233. https://doi.org/10.3390/v12111233
Gava C, Silva TCCD, Lyra DGP, Ardisson KS, Marques CS, Almada GL, et al. Yellow fever prevention and control: assessment of surveillance activities in a previously unaffected area in Brazil. Cad Saude Publica. 2022;38(1):e00000521. https://doi.org/10.1590/0102-311X00000521
Ribeiro AF, Cavalin RF, Suleiman JMAH, Costa JA, Vasconcelos MJ, Málaque CMS, et al. Yellow fever: factors associated with death in a hospital of reference in infectious diseases, São Paulo, Brazil, 2018. Am J Trop Med Hyg. 2019;101(1):180-8. https://doi.org/10.4269/ajtmh.18-0882
Kallas EG, D’Elia Zanella LGFAB, Moreira CHV, Buccheri R, Diniz GBF, Castiñeras ACP, et al. Predictors of mortality in patients with yellow fever: an observational cohort study. Lancet Infect Dis. 2019;19(7):750-8. https://doi.org/10.1016/S1473-3099(19)30125-2
Tuboi SH, Costa ZG, Vasconcelos PFC, Hatch D. Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998-2002. Trans R Soc Trop Med Hyg. 2007;101(2):169-75. https://doi.org/10.1016/j.trstmh.2006.04.001
Monath TP, Vasconcelos PF. Yellow fever. J Clin Virol. 2015;64:160-73. https://doi.org/10.1016/j.jcv.2014.08.030
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2025 Lucas Casagrande Passoni Lopes

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.